Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Toshiba Develops 0.25mm Multi-slice CT Technology
October 15, 2001
- Sales Up for 23 Generic Houses, Down for 22: EMA Survey
October 15, 2001
- Guidant Japan to Introduce New Defibrillator
October 15, 2001
- BUSINESS NEWS IN BRIEF -1-
October 15, 2001
- Mitsubishi Pharma Corp Starts Operation
October 8, 2001
- Bill for Healthcare Reform to Be Presented to Diet Next Year -2-
October 8, 2001
- Chugai to Withdraw from Medical Device Business
October 8, 2001
- Mochida, JCR Submit NDA for Thrombomodulin
October 8, 2001
- Major Objective Is Reinforcement of Ethical Drug Business: Taisho President
October 8, 2001
- Shionogi to Need 2 Years Before Obtaining Results of Restructuring
October 8, 2001
- Number of Diabetes Patients to Increase to 4.3 Mil. in 2010: Mr Nagae of Aventis
October 8, 2001
- BUSINESS NEWS IN BRIEF -1-
October 8, 2001
- BUSINESS NEWS IN BRIEF -2-
October 8, 2001
- Gastric Cancer Closely Linked with H. pylori Infection: Seminar
October 8, 2001
- Bill for Healthcare Reform to Be Presented to Diet Next Year -1-
October 8, 2001
- Losartan Shows Renal Protective Effects: NEJM
October 8, 2001
- WORLD NEWS IN BRIEF
October 8, 2001
- AIST, Toyo Shinyaku to Screen Plant Extracts That Kill Leukemia Cells
October 8, 2001
- Bill for Healthcare Reform to Be Presented to Diet Next Year -3-
October 8, 2001
- JPMA, ABPI Deepen R&D Exchanges
October 8, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…